Robert Thänert

674 total citations
14 papers, 383 citations indexed

About

Robert Thänert is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robert Thänert has authored 14 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Robert Thänert's work include Gut microbiota and health (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Urinary Tract Infections Management (3 papers). Robert Thänert is often cited by papers focused on Gut microbiota and health (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Urinary Tract Infections Management (3 papers). Robert Thänert collaborates with scholars based in United States, Germany and Netherlands. Robert Thänert's co-authors include Gautam Dantas, Eva Medina, Drew J. Schwartz, Oliver Goldmann, Andreas Beineke, Carey‐Ann D. Burnham, Phillip I. Tarr, Barbara Warner, Eric C. Keen and Meghan A. Wallace and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Medicine and Nature Communications.

In The Last Decade

Robert Thänert

14 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Thänert United States 9 183 112 80 66 42 14 383
Francisco J. Salazar‐Echegarai Chile 11 171 0.9× 90 0.8× 98 1.2× 24 0.4× 37 0.9× 16 462
Aurélie Derré‐Bobillot France 11 182 1.0× 65 0.6× 133 1.7× 58 0.9× 24 0.6× 15 429
Luz María Rocha-Ramírez Mexico 11 232 1.3× 94 0.8× 120 1.5× 60 0.9× 13 0.3× 27 524
Brigida Rusconi United States 12 123 0.7× 54 0.5× 82 1.0× 86 1.3× 17 0.4× 21 365
Catalina Pardo‐Roa Chile 11 131 0.7× 99 0.9× 143 1.8× 24 0.4× 28 0.7× 18 489
Alla Šplı́chalová Czechia 12 195 1.1× 41 0.4× 97 1.2× 79 1.2× 9 0.2× 36 426
Stephen Ward United Kingdom 10 120 0.7× 85 0.8× 141 1.8× 36 0.5× 13 0.3× 16 494
Izabela Glegola-Madejska United Kingdom 11 325 1.8× 72 0.6× 168 2.1× 26 0.4× 53 1.3× 11 564
Anne Six France 10 146 0.8× 173 1.5× 56 0.7× 9 0.1× 33 0.8× 12 499
Tsukasa Shiraishi Japan 13 161 0.9× 86 0.8× 42 0.5× 36 0.5× 129 3.1× 30 445

Countries citing papers authored by Robert Thänert

Since Specialization
Citations

This map shows the geographic impact of Robert Thänert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Thänert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Thänert more than expected).

Fields of papers citing papers by Robert Thänert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Thänert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Thänert. The network helps show where Robert Thänert may publish in the future.

Co-authorship network of co-authors of Robert Thänert

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Thänert. A scholar is included among the top collaborators of Robert Thänert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Thänert. Robert Thänert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Thänert, Robert, Carla Hall-Moore, I. Malick Ndao, et al.. (2025). Gut microbiome evolution from infancy to 8 years of age. Nature Medicine. 31(6). 2004–2015. 2 indexed citations
2.
Thänert, Robert, Drew J. Schwartz, Eric C. Keen, et al.. (2024). Clinical sequelae of gut microbiome development and disruption in hospitalized preterm infants. Cell Host & Microbe. 32(10). 1822–1837.e5. 12 indexed citations
3.
Thänert, Robert, et al.. (2022). The resistance within: Antibiotic disruption of the gut microbiome and resistome dynamics in infancy. Cell Host & Microbe. 30(5). 675–683. 46 indexed citations
4.
Thänert, Robert, et al.. (2022). Substantial overlap between symptomatic and asymptomatic genitourinary microbiota states. Microbiome. 10(1). 6–6. 8 indexed citations
5.
Thänert, Robert, Carey‐Ann D. Burnham, I. Malick Ndao, et al.. (2021). Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Gut Microbes. 13(1). 1940792–1940792. 24 indexed citations
6.
Thänert, Robert, Eric C. Keen, Gautam Dantas, Barbara Warner, & Phillip I. Tarr. (2020). Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions. The Journal of Infectious Diseases. 223(Supplement_3). S257–S263. 48 indexed citations
7.
Thänert, Robert, Kimberly A. Reske, Tiffany Hink, et al.. (2019). Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections. mBio. 10(4). 80 indexed citations
8.
Yoneda, Aki, Robert Thänert, Carey‐Ann D. Burnham, & Gautam Dantas. (2019). In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp. International Journal of Antimicrobial Agents. 55(2). 105864–105864. 7 indexed citations
9.
Thänert, Robert, Kimberly A. Reske, Tiffany Hink, et al.. (2019). 2847. Comparative Genomics and Clonal Tracking of Multi-drug-Resistant Uropathogens Implicates the Fecal Microbiome as a Potential Reservoir for Recurrent Urinary Tract Infections. Open Forum Infectious Diseases. 6(Supplement_2). S70–S71. 1 indexed citations
10.
Fetzer, Christian, Vadim S. Korotkov, Robert Thänert, et al.. (2017). Verringerung der Virulenz von multiresistentem Staphylococcus aureus mithilfe eines chemischen Disruptors des ClpX‐Chaperon‐Komplexes. Angewandte Chemie. 129(49). 15952–15957. 2 indexed citations
11.
Fetzer, Christian, Vadim S. Korotkov, Robert Thänert, et al.. (2017). A Chemical Disruptor of the ClpX Chaperone Complex Attenuates the Virulence of Multidrug‐Resistant Staphylococcus aureus. Angewandte Chemie International Edition. 56(49). 15746–15750. 33 indexed citations
12.
Koymans, Kirsten J., Oliver Goldmann, Christofer Karlsson, et al.. (2017). The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in vivo. Journal of Innate Immunity. 9(6). 561–573. 22 indexed citations
13.
Thänert, Robert, Oliver Goldmann, Andreas Beineke, & Eva Medina. (2017). Host-inherent variability influences the transcriptional response of Staphylococcus aureus during in vivo infection. Nature Communications. 8(1). 14268–14268. 56 indexed citations
14.
Jansen, Gunther, et al.. (2015). Evolutionary Transition from Pathogenicity to Commensalism: Global Regulator Mutations Mediate Fitness Gains through Virulence Attenuation. Molecular Biology and Evolution. 32(11). 2883–2896. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026